Astera Labs (NASDAQ:ALAB) Trading Down 4.7% Following Insider Selling

Astera Labs, Inc. (NASDAQ:ALAB) traded down 4.7% during trading on Thursday following insider selling activity. The company traded as low as $163.75 and last traded at $163.9260. 551,262 shares were traded during trading, a decline of 89% from the average session volume of 5,201,073 shares. The stock had previously closed at $172.09.

Specifically, CEO Jitendra Mohan sold 2,967 shares of the stock in a transaction that occurred on Wednesday, April 15th. The shares were sold at an average price of $174.60, for a total value of $518,038.20. Following the transaction, the chief executive officer owned 4,405,015 shares in the company, valued at approximately $769,115,619. This represents a 0.07% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 123,750 shares of the stock in a transaction that occurred on Friday, April 10th. The stock was sold at an average price of $149.68, for a total transaction of $18,522,900.00. Following the completion of the transaction, the chief executive officer owned 4,407,982 shares in the company, valued at approximately $659,786,745.76. This trade represents a 2.73% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Analyst Ratings Changes

A number of brokerages have recently commented on ALAB. Loop Capital began coverage on shares of Astera Labs in a research note on Thursday, March 5th. They set a “buy” rating and a $250.00 price objective on the stock. Weiss Ratings cut shares of Astera Labs from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Monday, February 23rd. Barclays set a $165.00 price objective on shares of Astera Labs in a research note on Thursday, January 15th. Royal Bank Of Canada began coverage on shares of Astera Labs in a research note on Wednesday, January 14th. They set an “outperform” rating and a $225.00 price objective on the stock. Finally, Citigroup began coverage on shares of Astera Labs in a research note on Thursday, April 2nd. They set a “buy” rating and a $200.00 price objective on the stock. Fifteen research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Astera Labs presently has a consensus rating of “Moderate Buy” and an average target price of $199.44.

Key Headlines Impacting Astera Labs

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Earnings beat, revenue growth and guidance support momentum — Astera Labs reported a sizable revenue beat and higher EPS with raised Q1 guidance, which underpins investor confidence and several buy/outperform analyst ratings. Astera Labs Trading Up 1.9%
• Positive Sentiment: Insider alignment highlighted in growth stock roundups — recent articles that spotlight growth companies with meaningful insider ownership include Astera Labs, reinforcing a narrative that management holds large stakes and is aligned with shareholders. April 2026’s Top Growth Companies With Strong Insider Ownership
• Neutral Sentiment: Market commentary on today’s move — coverage from market sites notes ALAB outpaced the broader market on the latest session; useful context but largely descriptive rather than new fundamental news. Why Astera Labs, Inc. (ALAB) Outpaced the Stock Market Today
• Neutral Sentiment: Institutional ownership and analyst coverage — institutional investors hold a majority stake and several firms have set price targets above current levels; this provides stability but also mixed target ranges. Astera Labs Trading Up 1.9%
• Negative Sentiment: CEO share sales — CEO Jitendra Mohan sold 2,967 shares (~$174.60 avg) on April 15 under a pre-arranged Rule 10b5-1 plan; recent prior sales mean continued insider liquidity, which some investors view as a modest negative despite plan safeguards. Astera Labs (NASDAQ:ALAB) CEO Sells $518,038.20 in Stock
• Negative Sentiment: Competitive comparison with Amphenol — analyst pieces comparing ALAB to larger, diversified peers (e.g., Amphenol) suggest APH may present a less risky exposure in data-infrastructure, which could cap upside for ALAB until market share or diversification improves. Amphenol vs. ALAB: Which Data Infrastructure Stock Should You Buy?

Astera Labs Stock Performance

The business’s 50 day moving average is $129.83 and its 200-day moving average is $154.36. The stock has a market cap of $29.81 billion, a price-to-earnings ratio of 142.66, a PEG ratio of 3.36 and a beta of 1.78.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings results on Tuesday, February 10th. The company reported $0.58 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.51 by $0.07. Astera Labs had a net margin of 25.70% and a return on equity of 16.12%. The firm had revenue of $270.58 million for the quarter, compared to analysts’ expectations of $249.46 million. During the same quarter last year, the company earned $0.37 EPS. The firm’s revenue for the quarter was up 91.8% compared to the same quarter last year. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. Sell-side analysts anticipate that Astera Labs, Inc. will post 0.34 EPS for the current fiscal year.

Institutional Investors Weigh In On Astera Labs

Institutional investors have recently added to or reduced their stakes in the stock. Assetmark Inc. grew its stake in Astera Labs by 374.1% in the 3rd quarter. Assetmark Inc. now owns 128 shares of the company’s stock valued at $25,000 after acquiring an additional 101 shares during the period. Reflection Asset Management acquired a new stake in Astera Labs in the 4th quarter valued at $25,000. Smartleaf Asset Management LLC grew its stake in Astera Labs by 422.2% in the 4th quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock valued at $32,000 after acquiring an additional 152 shares during the period. Hilltop National Bank grew its stake in Astera Labs by 100.0% in the 4th quarter. Hilltop National Bank now owns 200 shares of the company’s stock valued at $33,000 after acquiring an additional 100 shares during the period. Finally, Aventura Private Wealth LLC acquired a new stake in Astera Labs in the 4th quarter valued at $33,000. Institutional investors and hedge funds own 60.47% of the company’s stock.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.